Dr. David Eifrig recently prepared a special document for you.
| This advertisement is from DailyWealth, a free e-letter.
You can unsubscribe here but you will no longer receive DailyWealth. |
| | |
Editor's Note: Below is a note from Managing Director Jared Kelly, about an early access look you've been given for one of Stansberry's biggest breakthrough in years...
Dear Reader,
Dr. David Eifrig recently prepared a special document for you. It's based on a trading strategy he's spent the past 12 months developing and testing in secret… And today, you're getting early access to be one of the few to see what Doc has been working on. We've created an entire free briefing that gives you the details on Doc's new breakthrough before we go public and everyone else hears about this on Wednesday, December 5th.
So make sure you look at it before then. You'll discover… *How you can use this strategy to make 10 to 20 times more money on the same stocks *How we've achieved annualized gains of 619% over the past year *And how this strategy turns losing stocks into winners But there's only a few days until Doc's secret is spread among the masses. So, use your early access now and look over his free briefing. Sincerely, Jared Kelly
Managing Director, Stansberry Research |
|
|
All contents of this e-mail are copyright 2018 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.
DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.
You're receiving this email at [email protected]. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to [email protected].
To unsubscribe from this mailing, click here: Unsubscribe
|
|
|
